These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 19930154)
1. Phenotype and genotype in females with POU3F4 mutations. Marlin S; Moizard MP; David A; Chaissang N; Raynaud M; Jonard L; Feldmann D; Loundon N; Denoyelle F; Toutain A Clin Genet; 2009 Dec; 76(6):558-63. PubMed ID: 19930154 [TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular characterizations of novel POU3F4 mutations reveal that DFN3 is due to null function of POU3F4 protein. Lee HK; Song MH; Kang M; Lee JT; Kong KA; Choi SJ; Lee KY; Venselaar H; Vriend G; Lee WS; Park HJ; Kwon TK; Bok J; Kim UK Physiol Genomics; 2009 Nov; 39(3):195-201. PubMed ID: 19671658 [TBL] [Abstract][Full Text] [Related]
3. Novel mutation in the homeobox domain of transcription factor POU3F4 associated with profound sensorineural hearing loss. Schild C; Prera E; Lüblinghoff N; Arndt S; Aschendorff A; Birkenhäger R Otol Neurotol; 2011 Jun; 32(4):690-4. PubMed ID: 21555964 [TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of DFN3 patients with deletions in the POU3F4 locus and detection of carrier female using MLPA. Song MH; Lee HK; Choi JY; Kim S; Bok J; Kim UK Clin Genet; 2010 Dec; 78(6):524-32. PubMed ID: 20412083 [TBL] [Abstract][Full Text] [Related]
5. Novel and De Novo Mutations Extend Association of POU3F4 with Distinct Clinical and Radiological Phenotype of Hearing Loss. Pollak A; Lechowicz U; Kędra A; Stawiński P; Rydzanicz M; Furmanek M; Brzozowska M; Mrówka M; Skarżyński H; Skarżyński PH; Ołdak M; Płoski R PLoS One; 2016; 11(12):e0166618. PubMed ID: 27941975 [TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the POU3F4 gene in patients with clinical and radiographic evidence of X-linked mixed deafness with perilymphatic gusher. Friedman RA; Bykhovskaya Y; Tu G; Talbot JM; Wilson DF; Parnes LS; Fischel-Ghodsian N Ann Otol Rhinol Laryngol; 1997 Apr; 106(4):320-5. PubMed ID: 9109724 [TBL] [Abstract][Full Text] [Related]
8. HRCT and MRI findings in X-linked non-syndromic deafness patients with a POU3F4 mutation. Gong WX; Gong RZ; Zhao B Int J Pediatr Otorhinolaryngol; 2014 Oct; 78(10):1756-62. PubMed ID: 25175280 [TBL] [Abstract][Full Text] [Related]
9. The molecular basis of X-linked deafness type 3 (DFN3) in two sporadic cases: identification of a somatic mosaicism for a POU3F4 missense mutation. de Kok YJ; Cremers CW; Ropers HH; Cremers FP Hum Mutat; 1997; 10(3):207-11. PubMed ID: 9298820 [TBL] [Abstract][Full Text] [Related]
11. Multiple enhancers located in a 1-Mb region upstream of POU3F4 promote expression during inner ear development and may be required for hearing. Naranjo S; Voesenek K; de la Calle-Mustienes E; Robert-Moreno A; Kokotas H; Grigoriadou M; Economides J; Van Camp G; Hilgert N; Moreno F; Alsina B; Petersen MB; Kremer H; Gómez-Skarmeta JL Hum Genet; 2010 Oct; 128(4):411-9. PubMed ID: 20668882 [TBL] [Abstract][Full Text] [Related]
12. Deletion of and novel missense mutation in POU3F4 in 2 families segregating X-linked nonsyndromic deafness. Vore AP; Chang EH; Hoppe JE; Butler MG; Forrester S; Schneider MC; Smith LL; Burke DW; Campbell CA; Smith RJ Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1057-63. PubMed ID: 16365218 [TBL] [Abstract][Full Text] [Related]
13. Pou3f4 deficiency causes defects in otic fibrocytes and stria vascularis by different mechanisms. Song MH; Choi SY; Wu L; Oh SK; Lee HK; Lee DJ; Shim DB; Choi JY; Kim UK; Bok J Biochem Biophys Res Commun; 2011 Jan; 404(1):528-33. PubMed ID: 21144821 [TBL] [Abstract][Full Text] [Related]
14. X-linked hearing loss: two gene mutation examples provide generalizable implications for clinical care. Stanton SG; Griffin A; Stockley TL; Brown C; Young TL; Benteau T; Abdelfatah N Am J Audiol; 2014 Jun; 23(2):190-200. PubMed ID: 24687041 [TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characterization of POU3F4 mutations in multiple DFNX2 Chinese families. Su Y; Gao X; Huang SS; Mao JN; Huang BQ; Zhao JD; Kang DY; Zhang X; Dai P BMC Med Genet; 2018 Sep; 19(1):157. PubMed ID: 30176854 [TBL] [Abstract][Full Text] [Related]
16. Alport syndrome. Molecular genetic aspects. Hertz JM Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970 [TBL] [Abstract][Full Text] [Related]
17. Hypothalamic hamartomas and inner ear diverticula with X-linked stapes gusher syndrome - new associations? Anderson EA; Özütemiz C; Miller BS; Moss TJ; Nascene DR Pediatr Radiol; 2020 Jan; 50(1):142-145. PubMed ID: 31440883 [TBL] [Abstract][Full Text] [Related]
18. Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review. Bernardinelli E; Huber F; Roesch S; Dossena S Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371790 [TBL] [Abstract][Full Text] [Related]
19. Novel POU3F4 mutations and clinical features of DFN3 patients with cochlear implants. Lee HK; Lee SH; Lee KY; Lim EJ; Choi SY; Park RK; Kim UK Clin Genet; 2009 Jun; 75(6):572-5. PubMed ID: 19438930 [No Abstract] [Full Text] [Related]
20. Audiological and surgical evidence for the presence of a third window effect for the conductive hearing loss in DFNX2 deafness irrespective of types of mutations. Choi BY; An YH; Park JH; Jang JH; Chung HC; Kim AR; Lee JH; Kim CS; Oh SH; Chang SO Eur Arch Otorhinolaryngol; 2013 Nov; 270(12):3057-62. PubMed ID: 23400403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]